| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.21B | — |
| Operating expense | — | — |
| Net income | 192.80M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JAZZ returned +106.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +49.6% |
| 1 year | +106.5% |
| 5 years | +93.1% |
| 10 years | +105.3% |
| All-time high | $254.28 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in JAZZ would be worth today ›No. Jazz Pharmaceuticals plc has not paid a dividend in the past 12 months.
Jazz Pharmaceuticals plc stock trades on NASDAQ under the ticker symbol JAZZ.
Jazz Pharmaceuticals plc is part of the Healthcare sector.
Jazz Pharmaceuticals plc has a market cap of 16.51B USD, based on the latest quote.
